Calamos Advisors’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
3,300
-4,204
-56% -$2.71M 0.01% 674
2026
Q1
$3.91M Buy
+7,504
New +$3.81M 0.01% 593
2025
Q3
Sell
-18,100
Closed -$5.33M 957
2025
Q2
$5.33M Sell
18,100
-11,900
-40% -$2.65M 0.02% 542
2025
Q1
$5.93M Buy
+30,000
New +$6.55M 0.03% 490
2024
Q4
Sell
-6,300
Closed -$1.52M 927
2024
Q3
$1.49M Buy
6,300
+2,388
+61% +$553K 0.01% 637
2024
Q2
$958K Sell
3,912
-11,269
-74% -$2.39M ﹤0.01% 652
2024
Q1
$2.87M Sell
15,181
-4,041
-21% -$811K 0.01% 557
2023
Q4
$3.66M Buy
+19,222
New +$3.29M 0.02% 547
2019
Q2
Sell
-34,500
Closed -$1.81M 751
2019
Q1
$1.81M Sell
34,500
-900
-3% -$49K 0.01% 530
2018
Q4
$1.82M Buy
+35,400
New +$1.7M 0.01% 535
2017
Q4
Sell
-36,217
Closed -$1.34M 612
2017
Q3
$1.34M Sell
36,217
-2,973
-8% -$122K 0.01% 531
2017
Q2
$1.67M Sell
39,190
-8,944
-19% -$337K 0.01% 534
2017
Q1
$2.02M Buy
48,134
+39,057
+430% +$1.62M 0.02% 500
2016
Q4
$366K Buy
+9,077
New +$378K ﹤0.01% 583

Other funds holding FN

Calamos Advisors's FN Position: Q2 2026 in Review

Calamos Advisors reduced its Fabrinet (FN) stake by 56% in Q2 2026, selling an estimated $2.71M and leaving 3,300 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #674.

Calamos Advisors first reported a position in FN in Q4 2016 and has held it in 14 quarters since. The position peaked at $5.93M in Q1 2025. 752 funds tracked by Wall St. Rank hold FN as of Q2 2026.

  • Calamos Advisors held 3,300 shares of Fabrinet worth $1.85M as of Q2 2026.
  • Calamos Advisors sold 4,204 Fabrinet shares in Q2 2026, an estimated $2.71M.
  • Fabrinet made up 0.01% of Calamos Advisors's portfolio in Q2 2026, its #674 holding.
  • Calamos Advisors first reported a position in Fabrinet in Q4 2016 and has held it in 14 quarters since.
  • Calamos Advisors's Fabrinet position peaked at $5.93M in Q1 2025.
  • 752 funds tracked by Wall St. Rank held Fabrinet as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.